ABIM, Arora Board Review Settle Test Prep Questions Suit


Published On: June 16th, 2010

The ABIM has settled the original suit with Arora Board Review which claimed the test prep company “illegally obtained and disseminated copyrighted test questions” for use in Arora’s course.

See the rest here: 
ABIM, Arora Board Review Settle Test Prep Questions Suit

STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

Stop Panic Attacks
The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.

try-now

YouTube Video



Loading...


Did You Know Did you know:


In 2001, Asian Americans and Pacific Islanders had the highest tuberculosis case rate of all racial and ethnic populations in the United States

Related Posts

  • ABIM Cheating Scandal: Take a Look at Some Test Questions
    Questions from the ABIM exam and those allegedly used in a test-prep course, for your reading pleasure. ..
  • ABIM Sorts Through Physician Appeals Over Arora Sanctions
    An ABIM spokesman says most doctors are appealing and a number have obtained counsel. ..
  • Review Board That Approved Fake Study Calls it Quits
    Coast IRB originally thought it could remake the company after it was snagged by a government sting operation in which it approved a fake clinical trial. But now it’s closing shop. An institutional review board, which signs off on clinical trials and is responsible for looking out for the well-being of people who participate in them,..
  • After Google-Apple, Can Biogen Directors Sit on Genzyme Board?
    Activist Carl Icahn has shown a continued interest in the biotech industry, building on his view that Big Pharma wants to spend its cash piles on acquiring the smaller companies. But his latest effort, to gain board seats at beleaguered Genzyme, may face a substantial snag from antitrust laws, at least to Genzyme’s way of..
  • A.M. Vitals: Study Questions Genetic Test for Plavix
    Questioning the Use of a Genetic Test: A review of previously published research appearing in the Journal of the American Medical Association suggests that a genetic test for patients taking the anti-clotting drug Plavix doesn’t identify people at greater risk for a heart attack or other cardiac event, the WSJ reports . The FDA, which..
  • XMRV: Still Waiting For a Test
    Reliably testing potential blood donors or people with CFS for XMRV isn’t yet possible. ..
Leave a comment
Comments are closed.
« Dietary Advisory Committee: American Public Overweight, Undernourished ‘Social Mission’ Scores for Med School Make Waves »